The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Human Bone Marrow–Derived MSCs Can Home to Orthotopic Breast Cancer Tumors and Promote Bone Metastasis
Open accessPublished version of a preprint
Abstract
American women have a nearly 25% lifetime risk of developing breast cancer, with 20% to 40% of these patients developing life-threatening metastases. More than 70% of patients presenting with metastases have skeletal involvement, which signals progression to an incurable stage. Tumor–stroma cell interactions are only superficially understood, specifically regarding the ability of stromal cells to affect metastasis. In vivo models show that exogenously supplied human bone marrow–derived stem cells (hBMSC) migrate to breast cancer tumors, but no reports have shown endogenous hBMSC migration from the bone to primary tumors. Here, we present a model of in vivo hBMSC migration from a physiologic human bone environment to human breast tumors. Furthermore, hBMSCs alter tumor growth and bone metastasis frequency. These may home to certain breast tumors based on tumor-derived TGF-β1. Moreover, at the primary tumor level, interleukin 17B (IL-17B)/IL-17BR signaling may mediate interactions between hBMSCs and breast cancer cells. Cancer Res; 70(24); 10044–50. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Martin, F. T., Dwyer, R. M., Kelly, J., Khan, S., Murphy, J. M., Curran, C., Miller, N., Hennessy, E., Dockery, P., Barry, F. P., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0734-1 · Cited by 290
Research works printed but not linked: 19
- Manders, 2006, Clinical management of women with metastatic breast cancer: a descriptive study according to age group, BMC Cancer, 6:179
- Karnoub, 2007, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 449, 557, 10.1038/nature06188 · DOI · Paper page
- Klopp, 2007, Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment, Cancer Res, 67, 11687, 10.1158/0008-5472.CAN-07-1406 · DOI · Paper page
- Lazennec, 2008, Concise review: adult multipotent stromal cells and cancer: risk or benefit?, Stem Cells, 26, 1387, 10.1634/stemcells.2007-1006 · DOI · Paper page
- Kuperwasser, 2005, A mouse model of human breast cancer metastasis to human bone, Cancer Res, 65, 6130, 10.1158/0008-5472.CAN-04-1408 · DOI · Paper page
- Kang, 2003, A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, 3, 537, 10.1016/S1535-6108(03)00132-6 · DOI · Paper page
- Gattei, 1992, Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1), J Cell Biol, 116, 437, 10.1083/jcb.116.2.437 · DOI
- Moreau, 2007, Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model, Cancer Res, 67, 10304, 10.1158/0008-5472.CAN-07-2483 · DOI
- Mauney, 2005, Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion, Biomaterials, 26, 6167, 10.1016/j.biomaterials.2005.03.024 · DOI
- Proia, 2006, Reconstruction of human mammary tissues in a mouse model, Nat Protoc, 1, 206, 10.1038/nprot.2006.31 · DOI
- Teicher, 2001, Malignant cells, directors of the malignant process: role of transforming growth factor-beta, Cancer Metastasis Rev, 20, 133, 10.1023/A:1013177011767 · DOI · Paper page
- Tang, 2009, TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation, Nat Med, 15, 757, 10.1038/nm.1979 · DOI · Paper page
- Weaver, 1999, Functional culture models to study mechanisms governing apoptosis in normal and malignant mammary epithelial cells, J Mammary Gland Biol Neoplasia, 4, 193, 10.1023/A:1018781325716 · DOI
- Dittmer, 2009, Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10, Cell Mol Life Sci, 66, 3053, 10.1007/s00018-009-0089-0 · DOI
- Jung, 2009, Analysis of the expression profiles of cytokines and cytokine-related genes during the progression of breast cancer growth in mice, Oncol Rep, 22, 1141
- Wertheim, 2009, The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis, Proc Natl Acad Sci U S A, 106, 15855, 10.1073/pnas.0906993106 · doi:10.1073/pnas.0906993106
- Dunn, 2009, Genomic predictors of outcome and treatment response in breast cancer, Mol Diagn Ther, 13, 73, 10.1007/BF03256317 · DOI
- Huang, 2009, IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling, Cell Death Differ, 16, 1332, 10.1038/cdd.2009.74 · DOI · Paper page
- Kokubu, 2008, Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing, J Histochem Cytochem, 56, 89, 10.1369/jhc.7A7223.2007 · DOI
Cited by
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
Roccaro, A. M., Sacco, A., Maiso, P., Azab, A. K., Tai, Y.-T., Reagan, M., Azab, F., Flores, L. M., Campigotto, F., Weller, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66517 · Cited by 794
Self-citationThe Role of Cytokines in Breast Cancer Development and Progression
Esquivel-Velázquez, M., Ostoa-Saloma, P., Palacios-Arreola, M. I., Nava-Castro, K. E., Castro, J. I., & Morales-Montor, J. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0026 · Cited by 490
The microenvironment in breast cancer progression: biology and implications for treatment
Place, A. E., Jin Huh, S., & Polyak, K. (2011) · Breast Cancer Research · doi:10.1186/bcr2912 · Cited by 413
The metastasis-promoting roles of tumor-associated immune cells
Smith, H. A., & Kang, Y. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1021-5 · Cited by 367
Caicedo, A., Fritz, V., Brondello, J.-M., Ayala, M., Dennemont, I., Abdellaoui, N., de Fraipont, F., Moisan, A., Prouteau, C. A., Boukhaddaoui, H., et al. (2015) · Scientific Reports · doi:10.1038/srep09073 · Cited by 345
Metadata
- Authors
- Goldstein, R. H., Reagan, M. R., Anderson, K., Kaplan, D. L., & Rosenblatt, M.
- Venue
- Cancer Research
- Published
- 2010-12-14
- Volume
- 70
- Issue
- 24
- Pages
- 10044-10050
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2144906348
- Cited by
- 210
- References
- 2
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Bone Marrow–Derived MSCs Can Home to Orthotopic Breast Cancer Tumors and Promote Bone Metastasis. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-1254
- The paper
- Goldstein, R. H., Reagan, M. R., Anderson, K., Kaplan, D. L., & Rosenblatt, M. (2010). Human Bone Marrow–Derived MSCs Can Home to Orthotopic Breast Cancer Tumors and Promote Bone Metastasis. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-1254
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.